Cardiac Disease in Pregnancy

Management of High-Risk Pregnancy: An Evidence-Based Approach, Fifth Edition

Volumn , Issue , 2008, Pages 143-162

  Martin, Stephanie R ^a   Foley, Michael R ^b  

^a BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Aortic stenosis; Atrial septal defect; Cardiac disease; Congenital heart disease; Fetal cardiac abnormalities

Indexed keywords

EID: 84890980019     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470691878.ch17     Document Type: Chapter

References (137)

1. Ullery JC. The management of pregnancy complicated by heart disease. Am J Obstet Gynecol 1954;67:834-66.
2. Szekely P, Turner R, Snaith L Pregnancy and the changing pattern of rheumatic heart disease. Br Heart J 1973;35:1293-303.
3. De SM Maternal mortality from heart disease in pregnancy. Br Heart J 1993;69:524.
4. Hsieh TT, Chen KC, Soong JH. Outcome of pregnancy in patients with organic heart disease in Taiwan. Asia Oceania J Obstet Gynaecol 1993;19:21-7.
5. Chalupczak P, Kolasinska-Kloch W, Jach R, Basta A. Pregnancy in patients with heart disease. Clin Exp Obstet Gynecol 2004;31:271-3.
6. Berg CJ, Atrash HK, Koonin LM, Tucker M. Pregnancy-related mortality in the United States, 1987-1990. Obstet Gynecol 1996;88:161-7.
7. Hogberg U, Innala E, Sandstrom A. Maternal mortality in Sweden, 1980-1988. Obstet Gynecol 1994;84:240-4.
8. Koonin LM, Atrash HK, Lawson HW, Smith JC. Maternal mortality surveillance, United States, 1979-1986. MMWR CDC Surveill Summ 1991;40:1-13.
9. El-Solh AA, Grant BJ. A comparison of severity of illness scoring systems for critically ill obstetric patients. Chest 1996;110:1299-304.
10. Loverro G, Pansini V, Greco P, Vimercati A, Parisi AM, Selvaggi L. Indications and outcome for intensive care unit admission during puerperium. Arch Gynecol Obstet 2001;265:195-8.
11. Mabie WC, Sibai BM. Treatment in an obstetric intensive care unit. Am J Obstet Gynecol 1990;162:1-4.
12. Mahutte NG, Murphy-Kaulbeck L, Le Q, Solomon J, Benjamin A, Boyd ME. Obstetric admissions to the intensive care unit. Obstet Gynecol 1999;94:263-6.
13. Naylor DF Jr, Olson MM. Critical care obstetrics and gynecology. Crit Care Clin 2003;19:127-49.
14. Tang LC, Kwok AC, Wong AY, Lee YY, Sun KO, So AP. Critical care in obstetrical patients: an eight-year review. Chin Med J (Engl) 1997;110:936-41.
15. Zeeman GG, Wendel GD, Jr., Cunningham FG. A blueprint for obstetric critical care. Am J Obstet Gynecol 2003;188:532-6.
16. Clark SL, Cotton DB, Lee W, et al. Central hemodynamic assessment of normal term pregnancy. Am J Obstet Gynecol 1989;161:1439-42.
17. Elkayam U, Gleicher N. Hemodynamics and cardiac function during normal pregnancy and the puerperium. In: Elkayam U, Gleicher N, eds. Cardiac Problems in Pregnancy, 3rd edn. New York: Wiley-Liss, 1998; 3-19.
18. Capeless EL, Clapp JF. Cardiovascular changes in early phase of pregnancy. Am J Obstet Gynecol 1989;161:1449-53.
19. Gei AF, Hankins GD. Cardiac disease and pregnancy. Obstet Gynecol Clin North Am 2001;28:465-512.
20. Clark SL. Structural cardiac disease in pregnancy. In: Clark SL, Cotton DB, Phelan JP, eds. Critical Care Obstetrics. Oradell, N.J.: Medical Economics Books, 1987; 92.
21. Siu SC, Sermer M, Harrison DA, et al. Risk and predictors for pregnancy-related complications in women with heart disease. Circulation 1997;96:2789-94.
22. Siu SC, Sermer M, Colman JM, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 2001;104:515-21.
23. Siu SC, Colman JM, Sorensen S, et al. Adverse neonatal and cardiac outcomes are more common in pregnant women with cardiac disease. Circulation 2002;105:2179-84.
24. Dye TD, Gordon H, Held B, Tolliver NJ, Holmes AP Retrospective maternal mortality case ascertainment in West Virginia, 1985 to 1989. Am J Obstet Gynecol 1992;167:72-6.
25. Montana E, Khoury MJ, Cragan JD, Sharma S, Dhar P, Fyfe D. Trends and outcomes after prenatal diagnosis of congenital cardiac malformations by fetal echocardiography in a well defined birth population, Atlanta, Georgia, 1990-1994. J Am Coll Cardiol 1996;28:1805-9.
26. Rose V, Gold RJ, Lindsay G, Allen M. A possible increase in the incidence of congenital heart defects among the offspring of affected parents. J Am Coll Cardiol 1985;6:376-82.
27. Whittemore R, Hobbins JC, Engle MA. Pregnancy and its outcome in women with and without surgical treatment of congenital heart disease. Am J Cardiol 1982;50:641-51.
28. Driscoll DJ, Michels VV, Gersony WM, et al. Occurrence risk for congenital heart defects in relatives of patients with aortic stenosis, pulmonary stenosis, or ventricular septal defect. Circulation 1993;87(SUPPL):I114-20.
29. Presbitero P, Somerville J, Stone S, Aruta E, Spiegelhalter D, Rabajoli F. Pregnancy in cyanotic congenital heart disease: outcome of mother and fetus. Circulation 1994;89:2673-6.
30. Teerlink JR, Foster E. Valvular heart disease in pregnancy: a contemporary perspective. Cardiol Clin 1998;16:573-98,x.
31. Lupton M, Oteng-Ntim E, Ayida G, Steer PJ Cardiac disease in pregnancy. Curr Opin Obstet Gynecol 2002;14:137-43.
32. Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. JAMA 1997;277:1794-801.
33. Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. Clin Infect Dis 1997;25:1448-58.
34. Reimold SC, Rutherford JD. Clinical practice. Vulvular heart disease in pregnancy. N Engl J Med 2003;349:52-9.
35. Clark SL, Phelan JP, Greenspoon J, Aldahl D, Horenstein J Labor and delivery in the presence of mitral stenosis: central hemodynamic observations. Am J Obstet Gynecol 1985;152:984-8.
36. Bonow RO, Carabello B, de LA Jr, et al. Guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). Circulation 1998;98:1949-84.
37. Iung B, Cormier B, Elias J, et al. Usefulness of percutaneous balloon commissurotomy for mitral stenosis during pregnancy. Am J Cardiol 1994;73:398-400.
38. Kalra GS, Arora R, Khan JA, Nigam M, Khalillulah M. Percutaneous mitral commissurotomy for severe mitral stenosis during pregnancy. Catheter Cardiovasc Diagn 1994;33:28-30.
39. Sivadasanpillai H, Srinivasan A, Sivasubramoniam S, et al Long-term outcome of patients undergoing balloon mitral valvotomy in pregnancy. Am J Cardiol 2005;95:1504-6.
40. Silversides CK, Colman JM, Sermer M, Siu SC. Cardiac risk in pregnant women with rheumatic mitral stenosis. Am J Cardiol 2003;91:1382-5.
41. Hameed A, Karaalp IS, Tummala PP, et al. The effect of valvular heart disease on maternal and fetal outcome of pregnancy. J Am Coll Cardiol 2001;37:893-9.
42. Sheikh F, Rangwala S, DeSimone C, Smith HS, O'Leary AM. Management of the parturient with severe aortic incompetence. J Cardiothorac Vasc Anesth 1995;9:575-7.
43. Alderson JD. Cardiovascular collapse following epidural anaesthesia for Caesarean section in a patient with aortic incompetence. Anaesthesia 1987;42:643-5.
44. Savage DD, Devereux RB, Garrison RJ, et al. Mitral valve prolapse in the general population. 2. Clinical features: the Framingham Study. Am Heart J 1983;106:577-81.
45. Lao TT, Sermer M, MaGee L, Farine D, Colman JM. Congenital aortic stenosis and pregnancy: a reappraisal. Am J Obstet Gynecol 1993;169:540-5.
46. Silversides CK, Colman JM, Sermer M, Farine D, Siu SC. Early and intermediate-term outcomes of pregnancy with congenital aortic stenosis. Am J Cardiol 2003;91:1386-9.
47. Avila WS, Rossi EG, Ramires JA, et al. Pregnancy in patients with heart disease: experience with 1000 cases. Clin Cardiol 2003;26:135-42.
48. Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med 2000;160:191-6.
49. Hall JG, Pauli RM, Wilson KM. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 1980;68:122-40.
50. Ginsberg JS, Hirsh J, Turner DC, Levine MN, Burrows R. Risks to the fetus of anticoagulant therapy during pregnancy. Thromb Haemost 1989;61:197-203.
51. Weitz JI. Low-molecular-weight heparins. N Engl J Med 1997;337:688-98.
52. Aventis Pharmaceuticals Inc. Lovenox injection [package insert]. Bridgewater, NJ; 2002.
53. Seshadri N, Goldhaber SZ, Elkayam U, et al. The clinical challenge of bridging anticoagulation with low-molecularweight heparin in patients with mechanical prosthetic heart valves: an evidence-based comparative review focusing on anticoagulation options in pregnant and nonpregnant patients. Am Heart J 2005;150:27-34.
54. Rowan JA, McCowan LM, Raudkivi PJ, North RA. Enoxaparin treatment in women with mechanical heart valves during pregnancy. Am J Obstet Gynecol 2001;185:633-7.
55. Raschke RA, Guidry JR, Foley MR. Apparent heparin resistance from elevated factor VIII during pregnancy. Obstet Gynecol 2000;96:804-6.
56. Whitfield LR, Lele AS, Levy G. Effect of pregnancy on the relationship between concentration and anticoagulant action of heparin. Clin Pharmacol Ther 1983;34:23-8.
57. Olson JD, Arkin CF, Brandt JT, et al College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of unfractionated heparin therapy. Arch Pathol Lab Med 1998;122:782-98.
58. Bates SM, Greer IA, Hirsh J, Ginsberg JS. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(SUPPL):627S-44S.
59. Klein LL, Galan HL. Cardiac disease in pregnancy. Obstet Gynecol Clin North Am 2004;31:429-59; viii.
60. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002;39:1890-900.
61. Deal K, Wooley CF. Coarctation of the aorta and pregnancy. Ann Intern Med 1973;78:706-10.
62. Goodwin JF. Pregnancy and coarctation of the aorta. Lancet 1958;1:16-20.
63. Beauchesne LM, Connolly HM, Ammash NM, Warnes CA. Coarctation of the aorta: outcome of pregnancy. J Am Coll Cardiol 2001;38:1728-33.
64. Vriend JW, Drenthen W, Pieper PG, et al. Outcome of pregnancy in patients after repair of aortic coarctation. Eur Heart J 2005;26:2173-8.
65. Saidi AS, Bezold LI, Altman CA, Ayres NA, Bricker JT. Outcome of pregnancy following intervention for coarctation of the aorta. Am J Cardiol 1998;82:786-8.
66. Niwa K, PerloffJK, Bhuta SM, et al. Structural abnormalities of great arterial walls in congenital heart disease: light and electron microscopic analyses. Circulation 2001;103:393-400.
67. Bonderman D, Gharehbaghi-Schnell E, Wollenek G, Maurer G, Baumgartner H, Lang IM. Mechanisms underlying aortic dilatation in congenital aortic valve malformation. Circulation 1999;99:2138-43.
68. Lin AE, Lippe B, Rosenfeld RG. Further delineation of aortic dilation, dissection, and rupture in patients with Turner syndrome. Pediatrics 1998;102:e12.
69. Myung K, Park MD, eds. Pediatric Cardiology for Practitioners, 4th edn. St. Louis: Mosby, 2002.
70. Schaefer G, Arditi LI, Solomon HA, Ringland JE. Congenital heart disease and pregnancy. Clin Obstet Gynecol 1968;11:1048-63.
71. Gilman DH. Caesarean section in undiagnosed Eisenmenger's syndrome. Report of a patient with a fatal outcome. Anaesthesia 1991;46:371-3.
72. Jackson GM, Dildy GA, Varner MW, Clark SL. Severe pulmonary hypertension in pregnancy following successful repair of ventricular septal defect in childhood. Obstet Gynecol 1993;82(SUPPL):680-2.
73. Neilson G, Galea EG, Blunt A. Congenital heart disease and pregnancy. Med J Aust 1970;1:1086-8.
74. PerloffJK. Congenital heart disease and pregnancy. Clin Cardiol 1994;17:579-87.
75. Daehnert I, Ewert P, Berger F, Lange PE. Echocardiographically guided closure of a patent foramen ovale during pregnancy after recurrent strokes. J Interv Cardiol 2001;14:191-2.
76. Kozelj M, Novak-Antolic Z, Grad A, Peternel P. Patent foramen ovale as a potential cause of paradoxical embolism in the postpartum period. Eur J Obstet Gynecol Reprod Biol 1999;84:55-7.
77. Actis Dato GM, Cavaglia M, Aidala E, et al. Patent ductus arteriosus: follow-up of 677 operated cases 40 years later. Minerva Cardioangiol 1999;47:245-54.
78. Trulock EP, Edwards LB, Taylor DO, et al. The Registry of the International Society for Heart and Lung Transplantation: Twentieth Official adult lung and heart-lung transplant report, 2003. J Heart Lung Transplant 2003;22:625-35.
79. Gleicher N, Midwall J, Hochberger D, Jaffin H. Eisenmenger's syndrome and pregnancy. Obstet Gynecol Surv 1979;34:721-41.
80. Weiss BM, Zemp L, Seifert B, Hess OM. Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996. J Am Coll Cardiol 1998;31:1650-7.
81. Yentis SM, Steer PJ, Plaat F. Eisenmenger's syndrome in pregnancy: maternal and fetal mortality in the 1990s. Br J Obstet Gynaecol 1998;105:921-2.
82. Goodwin TM, Gherman RB, Hameed A, Elkayam U Favorable response of Eisenmenger syndrome to inhaled nitric oxide during pregnancy. Am J Obstet Gynecol 1999;180:64-7.
83. Lust KM, Boots RJ, Dooris M, Wilson J. Management of labor in Eisenmenger syndrome with inhaled nitric oxide. Am J Obstet Gynecol 1999;181:419-23.
84. Geohas C, McLaughlin VV. Successful management of pregnancy in a patient with eisenmenger syndrome with epoprostenol. Chest 2003;124:1170-3.
85. Martin JT, Tautz TJ, Antognini JF Safety of regional anesthesia in Eisenmenger's syndrome. Reg Anesth Pain Med 2002;27:509-13.
86. Devitt JH, Noble WH, Byrick RJ. A Swan-Ganz catheter related complication in a patient with Eisenmenger's syndrome. Anesthesiology 1982;57:335-7.
87. Penning S, Robinson KD, Major CA, Garite TJ. A comparison of echocardiography and pulmonary artery catheterization for evaluation of pulmonary artery pressures in pregnant patients with suspected pulmonary hypertension. Am J Obstet Gynecol 2001;184:1568-70.
88. Webb GD, Smallhorn JF, Therrien J, Redington AN. Congenital heart disease. In: Zipes DP, Libby P, Bonow RO, Braunwald E, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 7th edn. Saunders, 2005.
89. Waickman LA, Skorton DJ, Varner MW, Ehmke DA, Goplerud CP. Ebstein's anomaly and pregnancy. Am J Cardiol 1984;53:357-8.
90. Donnelly JE, Brown JM, Radford DJ. Pregnancy outcome and Ebstein's anomaly. Br Heart J 1991;66:368-71.
91. Connolly HM, Warnes CA. Ebstein's anomaly: outcome of pregnancy. J Am Coll Cardiol 1994;23:1194-8.
92. Wilson NJ, Clarkson PM, Barratt-Boyes BG, et al. Long-term outcome after the mustard repair for simple transposition of the great arteries: 28-year follow-up. J Am Coll Cardiol 1998;32:758-65.
93. Guedes A, Mercier LA, Leduc L, Berube L, Marcotte F, Dore A. Impact of pregnancy on the systemic right ventricle after a Mustard operation for transposition of the great arteries. J Am Coll Cardiol 2004;44:433-7.
94. Clarkson PM, Wilson NJ, Neutze JM, North RA, Calder AL, Barratt-Boyes BG. Outcome of pregnancy after the Mustard operation for transposition of the great arteries with intact ventricular septum. J Am Coll Cardiol 1994;24:190-3.
95. Lao TT, Sermer M, Colman JM. Pregnancy following surgical correction for transposition of the great arteries. Obstet Gynecol 1994;83:665-8.
96. Murphy JG, Gersh BJ, Mair DD, et al. Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot. N Engl J Med 1993;329:593-9.
97. Therrien J, Marx GR, Gatzoulis MA. Late problems in tetralogy of Fallot: recognition, management, and prevention. Cardiol Clin 2002;20:395-404.
98. Singh H, Bolton PJ, Oakley CM. Pregnancy after surgical correction of tetralogy of Fallot. Br Med J (Clin Res Ed) 1982;285:168-70.
99. Nissenkorn A, Friedman S, Schonfeld A, Ovadia J. Fetomaternal outcome in pregnancies after total correction of the tetralogy of Fallot. Int Surg 1984;69:125-8.
100. Lewis BS, Rogers NM, Gotsman MS. Successful pregnancy after repair of Fallot's tetralogy. S Afr Med J 1972;46:934-6.
101. Meijer JM, Pieper PG, Drenthen W, et al. Pregnancy, fertility, and recurrence risk in corrected tetralogy of Fallot. Heart 2005;91:801-5.
102. Child AH. Marfan syndrome: current medical and genetic knowledge: how to treat and when. J Card Surg 1997;12(SUPPL):131-5.
103. Lalchandani S, Wingfield M. Pregnancy in women with Marfan's Syndrome. Eur J Obstet Gynecol Reprod Biol 2003;110:125-30.
104. Lipscomb KJ, Smith JC, Clarke B, Donnai P, Harris R. Outcome of pregnancy in women with Marfan's syndrome. Br J Obstet Gynaecol 1997;104:201-6.
105. Meijboom LJ, Vos FE, Timmermans J, Boers GH, Zwinderman AH, Mulder BJ. Pregnancy and aortic root growth in the Marfan syndrome: a prospective study. Eur Heart J 2005;26:914-20.
106. Pyeritz RE, McKusick VA. The Marfan syndrome: diagnosis and management. N Engl J Med 1979;300:772-7.
107. Rossiter JP, Repke JT, Morales AJ, Murphy EA, Pyeritz RE. A prospective longitudinal evaluation of pregnancy in the Marfan syndrome. Am J Obstet Gynecol 1995;173:1599-606.
108. Expert consensus document on management of cardiovascular diseases during pregnancy. Eur Heart J 2003;24:761-81.
109. Shores J, Berger KR, Murphy EA, Pyeritz RE. Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome. N Engl J Med 1994;330:1335-41.
110. Pearson GD, Veille JC, Rahimtoola S, et al. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 2000;283:1183-8.
111. Tidswell M. Peripartum cardiomyopathy. Crit Care Clin 2004;20:777-88; xi.
112. Whitehead SJ, Berg CJ, Chang J. Pregnancy-related mortality due to cardiomyopathy: United States, 1991-1997. Obstet Gynecol 2003;102:1326-31.
113. Chang J, Elam-Evans LD, Berg CJ, et al. Pregnancy-related mortality surveillance: United States, 1991-1999. MMWR Surveill Summ 2003;52:1-8.
114. Midei MG, DeMent SH, Feldman AM, Hutchins GM, Baughman KL. Peripartum myocarditis and cardiomyopathy. Circulation 1990;81:922-8.
115. Demakis JG, Rahimtoola SH, Sutton GC, et al. Natural course of peripartum cardiomyopathy. Circulation 1971;44:1053-61.
116. Sutton MS, Cole P, Plappert M, Saltzman D, Goldhaber S. Effects of subsequent pregnancy on left ventricular function in peripartum cardiomyopathy. Am Heart J 1991;121:1776-8.
117. Elkayam U, Akhter MW, Singh H, et al Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 2005;111:2050-5.
118. Chapa JB, Heiberger HB, Weinert L, Decara J, Lang RM, Hibbard JU. Prognostic value of echocardiography in peripartum cardiomyopathy. Obstet Gynecol 2005;105:1303-8.
119. Lampert MB, Weinert L, Hibbard J, Korcarz C, Lindheimer M, Lang RM. Contractile reserve in patients with peripartum cardiomyopathy and recovered left ventricular function. Am J Obstet Gynecol 1997;176:189-95.
120. Sutton MS, Cole P, Plappert M, Saltzman D, Goldhaber S Effects of subsequent pregnancy on left ventricular function in peripartum cardiomyopathy. Am Heart J 1991;121:1776-8.
121. Elkayam U, Tummala PP, Rao K, et al. Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med 2001;344:1567-71.
122. Sliwa K, Forster O, Zhanje F, Candy G, Kachope J, Essop R. Outcome of subsequent pregnancy in patients with documented peripartum cardiomyopathy. Am J Cardiol 2004;93:1441-3; A10.
123. Ladner HE, Danielsen B, Gilbert WM. Acute myocardial infarction in pregnancy and the puerperium: a population-based study. Obstet Gynecol 2005;105:480-4.
124. Badui E, Enciso R Acute myocardial infarction during pregnancy and puerperium: a review. Angiology 1996;47:739-56.
125. Hankins GD, Wendel GD Jr, Leveno KJ, Stoneham J. Myocardial infarction during pregnancy: a review. Obstet Gynecol 1985;65:139-46.
126. Roth A, Elkayam U. Acute myocardial infarction associated with pregnancy. Ann Intern Med 1996;125:751-62.
127. Upshaw CB Jr. A study of maternal electrocardiograms recorded during labor and delivery. Am J Obstet Gynecol 1970;107:17-27.
128. Gowda RM, Khan IA, Mehta NJ, Vasavada BC, Sacchi TJ. Cardiac arrhythmias in pregnancy: clinical and therapeutic considerations. Int J Cardiol 2003;88:129-33.
129. Hameed AB, Foley MR. Cardiac disease in pregnancy. In: Foley MR, Strong TH Jr, Garite TJ, eds. Obstetric Intensive Care Manual, 2nd edn. McGraw-Hill, 2004: 96-112.
130. Schroeder JS, Harrison DC. Repeated cardioversion during pregnancy. Treatment of refractory paroxysmal atrial tachycardia during 3 successive pregnancies. Am J Cardiol 1971;27:445-6.
131. Natale A, Davidson T, Geiger MJ, Newby K. Implantable cardioverter-defibrillators and pregnancy: a safe combination?. Circulation 1997;96:2808-12.
132. Jaffe R, Gruber A, Fejgin M, Altaras M, Ben-Aderet N. Pregnancy with an artificial pacemaker. Obstet Gynecol Surv 1987;42:137-9.
133. Scott JR, Wagoner LE, Olsen SL, Taylor DO, Renlund DG. Pregnancy in heart transplant recipients: management and outcome. Obstet Gynecol 1993;82:324-7.
134. Kim KM, Sukhani R, SlogoffS, Tomich PG. Central hemodynamic changes associated with pregnancy in a longterm cardiac transplant recipient. Am J Obstet Gynecol 1996;174:1651-3.
135. Greenberg ML, Uretsky BF, Reddy PS, et al. Long-term hemodynamic follow-up of cardiac transplant patients treated with cyclosporine and prednisone. Circulation 1985;71:487-94.
136. Armenti VT, Radomski JS, Moritz MJ, Gaughan WJ, McGrory CH, Coscia LA. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. Clin Transpl 2003;131-41.
137. Branch KR, Wagoner LE, McGrory CH, et al. Risks of subsequent pregnancies on mother and newborn in female heart transplant recipients. J Heart Lung Transplant 1998;17:698-702.